Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
In retinitis pigmentosa, loss of cone photoreceptors leads to blindness, and preservation of cone function is a major therapeutic goal. However, cone loss is thought to occur as a secondary event resulting from degeneration of rod photoreceptors. Here we report a genome editing approach in which adeno-associated virus (AAV)-mediated CRISPR/Cas9 delivery to postmitotic photoreceptors is used to target the Nrl gene, encoding for Neural retina-specific leucine zipper protein, a rod fate determinant during photoreceptor development. Following Nrl disruption, rods gain partial features of cones and present with improved survival in the presence of mutations in rod-specific genes, consequently preventing secondary cone degeneration. In three different mouse models of retinal degeneration, the treatment substantially improves rod survival and preserves cone function. Our data suggest that CRISPR/Cas9-mediated NRL disruption in rods may be a promising treatment option for patients with retinitis pigmentosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A dual rAAVs system (rAAV.RKp.SpCas9; rAAV.U7.gRNA-Nrl) rescued vision in three mouse lines of rod retinal degeneration (Crx-Nrl -/-; rd10 or Pde6b -/-; Rho -/-) by knocking out Nrl in one or both alleles [219].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [219]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In recent years, viral vectors have been extensively applied to deliver CRISPR cassettes in vitro and in vivo largely owing to their high efficiency in gene delivery and long-term stable transgene expression [34, 58, 65].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [58]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 1×
“47) 64 .”
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“In contrast, the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 gene editing system can efficiently disrupt genes at desired loci, enabling complete gene KO 17 .”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“Five sequences with leading scores and three that were previously reported 23,24 (ET1 to ET8, see Supplementary Table 1 and Supplementary Fig.”
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Human photoreceptor topography
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902920402 · Cited by 3,167 · cited 1×
“Rods are dim-light-sensing neurons distributed throughout the retina with the highest densities just outside of the macula 2,4 , whereas cones respond to higher levels of light and mediate colour vision.”
Cited by
Items 201–282 of 282
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments
Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8
Long Non-Coding RNA PNKY Modulates the Development of Choroidal Neovascularization
Shi, L., Han, X., Liu, C., Li, X., Lu, S., Jiang, Q. L., & Yao, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836031 · Cited by 8
“Thus, it is vital for maintaining bodily homeostasis and preventing leakage and pathological substance delivery (Zhang et al., 2018).”
BackgroundCRISPR technology in human diseases
Feng, Q., Li, Q., Zhou, H., Wang, Z., Lin, C., Jiang, Z., Liu, T., & Wang, D. (2024) · MedComm · doi:10.1002/mco2.672 · Cited by 11
Wang, W., Guo, D.-Y., & Tao, Y. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.09.002 · Cited by 9
AAV-CRISPR Persistence in the Eye of the Beholder
Recchia, A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.007 · Cited by 7
CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases
Lin, W. V., Stout, J. T., & Weng, C. Y. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000252 · Cited by 7
Basic and Clinical Application of Adeno-Associated Virus–Mediated Genome Editing
He, X., Xie, H., Liu, X., & Gu, F. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.190 · Cited by 7
“…related to LCA10 in the mouse retina was deleted 62 ; the Nrl gene in rods in three different mouse models of retinal degeneration was disrupted 63 ; the genomic VEGFR2 locus related to angiogenesis-associated diseases was edited to abrogate angiogenesis in mouse models of neovascularization…”
Huang, J., Xian, B., Peng, Y., Zeng, B., Li, W., Li, Z., Xie, Y., Zhao, M., Zhang, H., Zhou, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02180-5 · Cited by 7
Roy, R. K., Debashree, I., Srivastava, S., Rishi, N., & Srivastava, A. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210708150439 · Cited by 8
de Camargo, J. P. K., Prezia, G. N. D. B., Shiokawa, N., Sato, M. T., Rosati, R., & Boldt, A. B. W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886461 · Cited by 8
Li, X., Ma, B., Liao, M., Li, L., Zhang, X., Du, M., Yu, J., He, S., & Yan, H. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2707207 · Cited by 8
“For example, Nrl knockdown prevents retinal degeneration [269], and reprogramming of photoreceptors can be used for vision rescue in mice [268].”
BackgroundAlsing, S., Lindholm, A. B., Haldrup, J., Jensen, E. G., Mikkelsen, J. G., Aagaard, L., Askou, A. L., & Corydon, T. J. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.898568 · Cited by 7
Pre- and postsynaptic alterations in the visual cortex of the P23H-1 retinal degeneration rat model
Martinez-Galan, J. R., García-Belando, M., Cabanes-Sanchis, J. J., & Caminos, E. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.1000085 · Cited by 8
“The numerous advances and the emergence of novel techniques for repairing the damaged retina in RP (Yu et al., 2017; Unal Eroglu et al., 2018), reveal the need to know whether RP affects the visual cortex structure because, although a future therapeutic strategy could partly restore the damaged retina, it might not ha…”
BackgroundOne-step in vivo gene knock-out in porcine embryos using recombinant adeno-associated viruses
Gao, M., He, Y., Zhu, X., Peng, W., Zhou, Y., Deng, Y., Liao, G., Wei Min, N. I., Li, Y., Jun, G., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1376936 · Cited by 7
“…have demonstrated successful delivery of the rAAV-CRISPR system to achieve functional restoration in various target tissues, including the eye (Ruan et al., 2017; Yu et al., 2017), liver (Yin et al., 2016), heart (Carroll et al., 2016; Xie et al., 2016), lung (Platt et al., 2014), and others.”
BackgroundViral delivery of genome-modifying proteins for cellular reprogramming
Mikkelsen, J. G. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.005 · Cited by 7
Gene and epigenetic editing in the treatment of primary ciliopathies
Molinari, E., & Sayer, J. A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.027 · Cited by 7
Correcting visual loss by genetics and prosthetics
Xue, K., & MacLaren, R. E. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.03.003 · Cited by 5
“…urope PM C Funders A uthor M anuscripts CRISPR gRNA and Cas9 enzyme-encoding transgene within AAV and delivering the gene editing vector into the subretinal space, it is possible to specifically disrupt the diseasecausing allele in the photoreceptors or RPE [Suzuki 2016; Yu 2017; McCullough 2019].”
BackgroundCRISPR/Cas9 mediated somatic gene therapy for insertional mutations: the vibrator mouse model
Fu, X., Zhu, J., Duan, Y., Lu, P., & Zhang, K. (2021) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbab021 · Cited by 5
“The mouse with the most severe tremor phenotype was given a highest score (5) and the mouse with no tremor was given a score of 0.”
BackgroundCellular Reprogramming in the Retina — Seeing the Light
Lü, Y., & Zhang, K. (2018) · New England Journal of Medicine · doi:10.1056/nejmcibr1713887 · Cited by 5
All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice
Liu, Z., Chen, S., Lo, C., Wang, Q. K., & Sun, Y. (2024) · JCI Insight · doi:10.1172/jci.insight.178159 · Cited by 4
“Present application of the AAV-delivered SpCas9 system requires packaging SpCas9 and its single-guide RNA (sgRNA) separately into two distinct AAV vectors owing to the constrained cargo capacity of a single AAV vector (18, 19).”
InfluentialMolecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
Hussen, B. M., Ismael, B. S., Abdulla, S. S., Jamal, N. H., Mustafa, S. A., Najmalddin, Z. B., & Rasul, M. F. (2024) · BioMed Target Journal · doi:10.59786/bmtj.221 · Cited by 5
Dai, M., Yang, N., Xu, K., Zhang, J., Li, X., Zhang, Y., & Li, W. (2023) · Cell Proliferation · doi:10.1111/cpr.13565 · Cited by 4
Gene therapy in hereditary retinal dystrophy
Chien, J.-Y., & Huang, S. (2022) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_78_22 · Cited by 4
“In a mouse animal model, the AAV 8 vector delivered SpCas9, and sgRNA was subretinally injected and recused the visual function and delayed Nrl disruption in photoreceptors [46].”
BackgroundApplications of CRISPR/CAS9 Technology in Mice and Livestock Genome Editing: Current Research
Maj, D., & Górka, K. (2024) · Annals of Animal Science · doi:10.2478/aoas-2024-0078 · Cited by 4
Kruczek, K., & Swaroop, A. (2023) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2023.09.003 · Cited by 4
Self-citationKaur, K. K. (2022) · Current Trends in Biomedical Engineering & Biosciences · doi:10.19080/ctbeb.2022.20.556046 · Cited by 4
Corso‐Díaz, X., Liang, X., Preston, K., Tegshee, B., English, M. A., Nellissery, J. K., Yadav, S. P., Marchal, C., & Swaroop, A. (2024) · eLife · doi:10.7554/elife.103259 · Cited by 5
“Continued expression of NRL is essential for maintaining rod function ( Yu et al., 2017 ), and mutations affecting NRL activity are associated with retinopathies ( Bessant et al., 1999 ; Nishiguchi et al., 2004 ; Kanda et al., 2007 ; El-Asrag et al., 2022 ).”
Self-citationNovel approach to antiangiogenic factors in age-related macular degeneration therapy
Samelska, K., Kupis, M., Izdebska, J., Kamińska, A., & Skopiński, P. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.113103 · Cited by 4
The application of CRISPR-Cas9 system in brain diseases
Miao, Y., Li, C., Su, Y., Peng, T., Wang, J., Liu, S., Ma, C., Li, L., & Wang, Y. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2629031 · Cited by 3
Gelder, R. N. V. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000386 · Cited by 3
Monodispersed covalent organic framework nanocrystals in aqueous solution for DNA inclusion
Lyu, X., Yi, L., Zhang, L., Liu, J., & Deng, H. (2023) · Science China Chemistry · doi:10.1007/s11426-023-1674-7 · Cited by 3
Contribution of CRISPRable DNA to human complex traits
Zhai, R., Zheng, C., Yang, Z., Li, T., Chen, J., & Shen, X. (2022) · Communications Biology · doi:10.1038/s42003-022-03969-7 · Cited by 3
Self-citationGene therapies in pediatric ophthalmology
Daruich, A., Robert, M. P. A., & Brémond‐Gignac, D. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1188522 · Cited by 6
“Other mutation-independent strategies tested in mouse models of retinal degeneration aimed to promote photoreceptor cell survival, as a CRISPR-mediated knockdown of the key transcription factor Neural Retina Leucine zipper (Nrl), or a viralmediated expression of the rod-derived cone viability factor (RdCVF) (32, 33).”
BackgroundKey to Delivery: The (Epi-)genome Editing Vector Toolbox
Just, S., & Büning, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_7 · Cited by 3
Mechanisms of photoreceptor protection upon targeting the Nrl–Nr2e3 pathway
Murphy, D. P., Kolesnikov, A. V., Montana, C. L., Khaja, Z. M., Liu, Y., Kefalov, V. J., & Corbo, J. C. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2500446122 · Cited by 2
Revisiting retinal and macular degeneration in the genomics era
Swaroop, A., & Roska, B. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00960-4 · Cited by 3
Self-citationZaki, H. F., Bishri, J., Muqtadir, M. A., & Abu-Zaid, A. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111119 · Cited by 2
An Overview on the Genetic Etiology, Testing, and Therapeutic Options for Retinitis Pigmentosa
Srikrupa, N. N., Gnanasekaran, H., Kandeeban, S., Sundaramurthy, S., & Sripriya, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-4247-0_12 · Cited by 4
Update on gene therapies in pediatric ophthalmology
Brémond‐Gignac, D., Robert, M. P. A., & Daruich, A. (2023) · Archives de Pédiatrie · doi:10.1016/s0929-693x(23)00226-9 · Cited by 3
In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration
Lee, H., Jang, H., Chae, J., Lee, H. K., Son, C., Park, C., Ha, T., Yum, M.-J., Park, S., Hong, S. W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07299-6 · Cited by 5
“Previously, Yu et al. demonstrated in Nrl ‑knockout models that rod photoreceptors can acquire cone‑like morphological features 25 .”
InfluentialWhitaker, D. T., Mondal, A. K., Fann, H., Hargrove, P. J., Brooks, M. J., Chaitankar, V., Yu, W., Wu, Z., Kim, S., & Swaroop, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/753012 · Cited by 2
Self-citationEstablishing a human cell-based model system for macular degeneration
Neiteler, A. (2019) · ERA · doi:10.7488/era/8 · Cited by 3
Birch, D. G., & Fahim, A. T. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197659403.003.0029 · Cited by 1
Nucleic acid drug delivery in ophthalmology: Emerging trends and future perspectives
Yang, H., Zuo, J., Lv, S., Wei, X., Pan, M., Zhu, Z., Wang, Y., Jie, Y., Lu, Z., & Zhang, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114729 · Cited by 1
Galdikaitė, E., Krušnauskas, R., Henderson, E., & Bujakowska, K. M. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101462 · Cited by 1
“…of RCD due to mutations in rod-specific genes Rho (cid:0) / (cid:0) , Pde6b R560C/R560C (rd10), as well as transgenic RHO-P347S lines led to the reprogramming of rods toward a cone-like fate and significantly delayed retinal degeneration in all three models (Yu et al., 2017; Zhu et al., 2017).”
Krishnamoorthy, V., & Haigh, J. J. (2021) · Re GEN Open · doi:10.1089/regen.2021.0003 · Cited by 1
Advances and challenges in photoreceptor repair and regeneration
Guo, D., Ru, J., Xu, S., & Liu, C. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0114 · Cited by 1
Recent advances on modeling retinal disease: Towards efficient gene/drug therapy
Dolatabadi, E. N., Zaky, M. R. A., Abbas, F. H., Milani, A. E., André, H., & Alizadeh, E. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110416 · Cited by 1
Genetic profiling of a cone-dominated retina and cone photoreceptor subtypes
Kunze, V. P. (2017) · Carl von Ossiezky University of Oldenburg · Cited by 1
Soltaninejad, H., Khoshandam, M., Hamidieh, A. A., & Hosseinkhani, S. (2022) · doi:10.22541/au.165268627.74823408/v1 · Cited by 1
Commentary: CRISPR gene editing for inherited retinal dystrophies: Towards clinical translation
Bansal, M., & Chakraborty, D. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1010_22 · Cited by 1
“These rods show improved survival in the presence of mutations in rod‐specific genes, consequently preventing secondary cone degeneration; this was shown in Rhodopsin knockout mice.[9]”
BackgroundRestoration of visual function by transplantation of optogenetically engineered photoreceptors
Lampič, M. (2019) · theses.fr (ABES) · doi:10.70675/acd6f967zf519z4098z879ez13764b7697bc · Cited by 1
Histogenesis: Cone Photoreceptor Development
Olmos, O. E. O., Almeida, A. R., & Brzezinski, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00098-0 · Cited by 1
Modeling 3D Retinogenesis in Mouse Embryonic Stem Cells Following CRISPR-mediated Crx Knockdown
Prasad, P. (2017) · Dominican Scholar (Dominican University of California) · doi:10.33015/dominican.edu/2017.bio.04
Photoreceptor Telodendria Morphology and Connectivity in the Zebrafish Retina
Noel, N. C. L. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30v89x29
Dooley, S. J. (2018) · ScholarlyCommons (University of Pennsylvania)
Development of CRISPR/Cas-mediated gene editing in the retina
Li, F. (2020) · UTAS Research Repository · doi:10.25959/23249972
Gao, M., Zhu, X., Wang, S., Zhang, B., Zhang, Y., He, Y., Zhou, Y., Li, S., Yang, G., Liao, G., et al. (2021) · PubMed Central · doi:10.7507/1001-5515.202006032 · Cited by 1
Investigating Disease Presentation and Mechanism in RP1L1-Associated Photoreceptor Degeneration
Noel, N. C. L. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-6bg3-1e79
Innate Immunity and the Retinal Pigment Epithelium in Gene Therapy for Inherited Retinal Disorders
Casey, G. A. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-px5t-6n74
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11 · Cited by 1
Daghsni, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99987-8.00004-7
Transient CRISPR-Cas delivery for therapeutic gene editing in the retina
Botto, C. (2022) · theses.fr (ABES) · doi:10.70675/b0c6037fz0240z4844z9036z7867f920dadc
Precision ophthalmology: a call for Africa not to be left in the dark
Roberts, L. J. (2024) · Gene Therapy · doi:10.1038/s41434-024-00448-y · Cited by 1
“…CRISPR/Cas9-mediated cellular reprogramming has been shown to convert a mutation-sensitive cell type to a mutation-resistant cell type, i.e., a rod photoreceptor to a cone-like photoreceptor [15, 16], and induced pluripotent stem cell technology is being developed to regenerate retinal cells [14].”
BackgroundCorbo, J. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00145-6
Corso‐Díaz, X., Liang, X., Preston, K., Tegshee, B., English, M. A., Nellissery, J. K., Yadav, S. P., Marchal, C., & Swaroop, A. (2025) · eLife · doi:10.7554/elife.103259.3 · Cited by 1
Self-citationCorso‐Díaz, X., Liang, X., Preston, K., Tegshee, B., English, M. A., Nellissery, J. K., Yadav, S. P., Marchal, C., & Swaroop, A. (2024) · eLife · doi:10.7554/elife.103259.1 · Cited by 1
Self-citationBansal, M. (2023) · Delhi Journal of Ophthalmology · doi:10.4103/dljo.dljo_16_23
Corso‐Díaz, X., Liang, X., Preston, K., Tegshee, B., English, M. A., Nellissery, J. K., Yadav, S. P., Marchal, C., & Swaroop, A. (2025) · eLife · doi:10.7554/elife.103259.2
Self-citationChen, J., Bian, X., Zheng, X., Peng, B., Li, R., Du, H., Zhou, L., & Wen, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149741
Huang, J., Xian, B., Peng, Y., Zeng, B., Li, W., Li, Z., Xie, Y., Zhao, M., Zhang, H., Zhou, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14196505
柯屹峰, Fan, X., Hao, R., Dong, L., Xue, M., Tan, L., Yang, C., Li, X., & Ren, X. (2021) · Figshare · doi:10.6084/m9.figshare.13545305
Self-citationStudy of the Luteinizing Hormone Receptor in the CNS
Bhatta, S. (2020) · OhioLink ETD Center (Ohio Library and Information Network)
Role of the Glycogen Synthase Kinase 3 for the Retinal Development and Homeostasis
Braginskaja, E. (2018) · theses.fr (ABES) · doi:10.70675/72532a81z164ez4786z8c84zaf55afbdfa1d
“The protective effect of transforming rods into cones was demonstrated in three different models of retinal degeneration thus adding a new therapeutic strategy (Yu et al., 2017).”
Vertebrate opsin-based optogenetics for highly sensitive vision restoration
Rucli, M. (2024) · theses.fr (ABES) · doi:10.70675/3d316836ze86bz4f4ezbd75z8217449fe0e7
Downregulating Nrl Expression and Rod Photoreceptor Protection
Li, Y., Jiao, S., Tao, W., & Wen, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114683
Preston, K., Arya, M., Kumari, A., Nellissery, J. K., Brooks, M. J., Batz, Z. A., Liang, X., Tosini, G., & Swaroop, A. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.6.9
Self-citationApplications of CRISPR-Cas9 Genome Editing Technology in the Treatment of Human Diseases
Başer, E. (2026) · International journal of high school research · doi:10.36838/ijhsr810.19
From microbiome to macula: The role of probiotics in retinal neuroprotection
Goyal, S., & Vanita, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45154-6.00014-3
Metadata
- Authors
- Yu, W., Mookherjee, S., Chaitankar, V., Hiriyanna, S., Kim, J.-W., Brooks, M., Ataeijannati, Y., Sun, X., Dong, L., Li, T., Swaroop, A., & Wu, Z.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wu, Zhijian
- ORCID
- Venue
- Nature Communications
- Published
- 2017-03-14
- Volume
- 8
- Issue
- 1
- Pages
- 14716-14716
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5355895
- OpenAlex
- W2620315774
- Cited by
- 271
- References
- 70
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 23 · 2023: 21 · 2022: 35 · 2021: 41 · 2020: 38 · 2019: 24 · 2018: 51 · 2017: 20
- FWCI
- 14.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Eye Institute
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retinitis pigmentosa, CRISPR/Cas9 genome editing, AAV gene delivery, rod photoreceptors, cone photoreceptors, retinal degeneration, gene therapy, mouse model
- MeSH terms
- Gene Editing, Dependovirus, Animals, Cell Survival, Eye Proteins, Retinal Degeneration, Retinitis Pigmentosa, Retinal Rod Photoreceptor Cells, Retinal Cone Photoreceptor Cells, Basic-Leucine Zipper Transcription Factors, Mice, Gene Knockdown Techniques, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.